ITIL-168 in Advanced Melanoma
Public ClinicalTrials.gov record NCT05050006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes (TILs) in Subjects With Advanced Melanoma (DELTA-1)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
DELTA-1 is a phase 2 clinical trial to evaluate the efficacy and safety of ITIL-168 in adult subjects with advanced melanoma who have previously been treated with a PD-1 inhibitor. ITIL-168 is a cell therapy derived from a patient's own tumor-infiltrating immune cells (lymphocytes; TILs).
Study identification
- NCT ID
- NCT05050006
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2021 (Actual)
- Primary completion
- Feb 27, 2023 (Actual)
- Completion
- Feb 27, 2023 (Actual)
- Last update posted
- Apr 16, 2024
2021 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego, Moores Cancer Center | La Jolla | California | 92093 | — |
| The Angeles Clinic and Research Institute | Los Angeles | California | 90025 | — |
| USC - Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| UCLA Health - Westwood Cancer Care | Los Angeles | California | 90095 | — |
| Stanford Cancer Institute | Stanford | California | 94305 | — |
| University of Colorado - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| The University of Miami - Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Orlando Health Cancer Institute | Orlando | Florida | 32806 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Rush University Cancer Center | Chicago | Illinois | 60612 | — |
| Loyola University Chicago | Maywood | Illinois | 60153 | — |
| University of Louisville, James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Minnesota, Masonic Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Atlantic Health System - Morristown Medical Center | Morristown | New Jersey | 07962 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05050006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05050006 live on ClinicalTrials.gov.